Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

721 recalls, newest first

Class II · Moderate risk

Walgreens

Chemical Contamination: Presence of benzene

Ongoing Chemical / undeclared Sigan Industries Group Inc. D-0274-2025
Class II · Moderate risk

Neupogen (filgrastim)

Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.

Ongoing Stability / shelf life Amgen, Inc. NDC 55513-546-01 D-0286-2025
Class II · Moderate risk

Neupogen (filgrastim)

Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.

Ongoing Stability / shelf life Amgen, Inc. NDC 55513-530-01 D-0285-2025
Class II · Moderate risk

Prasugrel Tablets

Failed Dissolution Specifications - low dissolution results

Ongoing Dissolution failure Mylan Pharmaceuticals INC NDC 0378-5185-93 D-0280-2025
Class II · Moderate risk

Zapzyt

Chemical Contamination: Presence of benzene.

Ongoing Chemical / undeclared Denison Pharmaceuticals, LLC NDC 71687-0011-1 D-0273-2025
Class I · High risk

Vitality

Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.

Ongoing Chemical / undeclared One Source Nutrition, Inc, D-0281-2025
Class I · High risk

POTASSIUM CHLORIDE Inj.

Labeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEq

Ongoing Labeling / mix-up ICU Medical, Inc. NDC 0990-7074-26 D-0268-2025

Recalls by year